Industry News

Imidazoline quinolones

Advances in mTOR Inhibitors

A mass of studies have revealed that mTOR is a serine/threonine protein kinase closely related to the occurrence of A mass of studies have revealed that mTOR is a serine/threonine […]

drug

Approved Carbohydrate-based Drugs During 2000-2021

As the basic substance of life, carbohydrate molecules participate in almost all aspects of life activities and play various important biological functions. Based on the extensive biological functions of carbohydrate, […]

amino acid

Small Molecule Kinase Inhibitors Approved by FDA in 2021

Kinases have become an extremely important molecular target for a range of therapeutic targets. The kinase inhibitors are a large group of unique and potent antineoplastic agents which specifically target […]

virus

Proteasome and Proteasome Inhibitors

Proteasome is the main pathway by which misfolded proteins and other proteins are proteolyzed during protein synthesis. It is found in all eukaryotic cells, archaea and some bacteria and is […]

FDA-Approved Nucleic Acid Drugs

With the continuous development of molecular biology technology, the relationship between gene mutations and diseases has gained more and more in-depth understanding. Nucleic acids have attracted much attention because of […]

Summary of Research in 2020

Summary of Research in 2020

2020 was a year of COVID-19’s wreak havoc, and also a year of rapid growth in biomedicine. We recorded the development of the industry news. Popular targets PD-1 Although PD-1 […]

Research Progresses on Breast Cancer

Research Progresses on Breast Cancer

Breast cancer is the most common cancer among women worldwide, which is a disease in which breast cells grow out of control. Breast cancer is the second leading cause of cancer […]

Recent Progresses on Diabetes

Recent Progresses on Diabetes

Nearly 500 million people in the world suffer from diabetes, mainly type 2 diabetes, and this number is expected to soar in the next few years. Diabetes is also associated […]

NEJM: Remdesivir for the Treatment of Covid-19-Final Report

With the development of the global epidemic, remdesivir has received continuous attention from the industry and the public. Earlier, preliminary results of a global clinical trial called ACTT-1 sponsored by the American […]

New Progresses on Cancer Immunotherapy

New Progresses on Cancer Immunotherapy

1 Blocking the function of special proteins may increase the effectiveness of immunotherapy Immunotherapy can attack cancer cells by stimulating the patient’s own immune system, which can quickly alleviate the diseases […]